CClinicalTrials.gg
TerminatedNCT00607061glutathioneUpdated Sep 30, 2013

Synthesis of Glutathione From Low Birth Weight Newborn Babies

An interventional study of Blood sample collection in Low Birth Weight, sponsored by Nantes University Hospital. Terminated at 1 site in France. Open to participants aged Up to 9 Months. Per ClinicalTrials.gov, last updated 2013-09-30.

Sponsored by Nantes University Hospital · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Non-randomized
Ages
Up to 9 Months
Sex
All
01

Study summary

The aim of the study is to determine mechanisms leading to glutathione deficiency in low birth weight newborn babies. Compared to full term neonates, depletion in this population may be due to a decreased synthesis rate or to an enhanced utilization or a combination of both mechanisms.The protocol is constituted of two steps. The objective of the first step is to quantify the blood concentration of glutathione in the artery and the vein of umbilical cord in full term newborn babies. Objectives of the second step are to determine if the glutathione synthesis rate, measured in vitro, is lower in erythrocytes collected from umbilical cord blood of low weight newborn babies compared to full term newborn babies. In this case, the next objective will be to determine if the adjunction of an excess of cysteine in vitro can restore the glutathione synthesis rate in these cells.

02

Conditions studied

  • Low Birth Weight

Keywords

  • Glutathione
  • Cysteine
  • Synthesis rate
  • Newborns
  • Low birth weight newborn babies
03

In context

Body Weight

1,223 studies on the registry are indexed under Body Weight; 131 are open to participants now.

This study's enrollment of 35 is below the median of 64 across 947 interventional studies indexed under Body Weight.

Browse Body Weight studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 825 studies on the registry; 195 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 9 Months
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria (first step):

  • Full term newborn babies
  • Gestational age > 37 weeks of amenorrhea and weight of birth > tenth percentile
  • Eutocic delivery

Inclusion Criteria (second step):

  • Low birth weight newborn babies (gestational age \< 32 weeks of amenorrhea and/or weight of birth \< 1500 g and/or weight of birth \< third percentile for their gestational age)
  • Full term newborn babies (gestational age > 37 weeks of amenorrhea and weight of birth > tenth percentile)

Exclusion criteria (first and second step):

  • Mother diastolic blood pressure > 90 mmHg during pregnancy,
  • pH \< 7.2 at umbilical cord and/or difference in pH \< 0,02 between arterial pH and venous pH
  • Dystocic delivery
  • Bacterial or viral maternofoetal infection
  • Foetal malformation
  • Foetal disease
  • Taking N-acetyl-cystein or vitamines and antioxidant minerals by the mother for the last 24 hours
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Other
    1

    Full term newborn babies with gestational age \> 37 weeks of amenorrhea and weight of birth \> tenth percentile.

    Procedure: Blood sample collection

  • Other
    2

    Low birth weight newborn babies (gestational age \< 32 weeks of amenorrhea and/or weight of birth \< 1500 g and/or weight of birth \< third percentile for their gestational age.

    Procedure: Blood sample collection

  • Other
    3

    Full term newborn babies (gestational age \> 37 weeks of amenorrhea and weight of birth \> tenth percentile).

    Procedure: Blood sample collection

Interventions

  • ProcedureBlood sample collection

    Blood of the umbilical cord will be collected after delivery. A mother blood sample will be also collected in the few hours preceding delivery to determine glutathione and cysteine concentrations.

06

What researchers measure

Primary outcomes

  1. The glutathione concentration in umbilical cord in full term newborn babies, the glutathione concentration in umbilical cord of low birth weight newborn babies and the effect of the adjunction of an excess of cysteine on the glutathione synthesis rate.

07

Study locations

1 site
  • CHU de Nantes
    Nantes, 44000, France
08

References and documents

Publications

  • De Luca A, Kuster A, Tea I, Darmaun D, Roze JC, Robins R, Hankard R. Plasma amino acid pools in the umbilical cord artery show lower 15N natural isotope abundance relative to the maternal venous pools. Isotopes Environ Health Stud. 2021 Mar;57(1):3-10. doi: 10.1080/10256016.2020.1817914. Epub 2020 Sep 24. PubMed 32972258 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 30, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00607061
Lead sponsor
Nantes University Hospital
First posted
Feb 5, 2008
Start date
Oct 2007
Primary completion
Jul 2010
Completion
Jul 2010
Last update
Sep 30, 2013

Study contacts

Alice KUSTER, Doctor
principal investigator · Nantes University Hospital
Norbert WINER, Doctor
study chair · Nantes University Hospital
Jean-Christophe ROZE, Professor
study chair · Nantes University Hospital
Dominique DARMAUN, Professor
study chair · Nantes University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion